Impact of concomitant proton pump inhibitors in patients treated for advanced or metastatic NSCLC: a target trial emulation protocol
Authors:
- F. Le BorgneFBF. Le Borgne
- A. De MontfortAMA. De Montfort
- B. GuegoBGB. Guego
- E. MartinEME. Martin
- C. GuerinCGC. Guerin
- L. BosquetLBL. Bosquet
- F. BocquetFBF. Bocquet
- M. RobainMRM. Robain
- J.-L. RaoulJRJ.-L. Raoul
- D. PérolDPD. Pérol
Open Access
- 12 August 2026
- journal article
- Published by Elsevier in ESMO Real World Data and Digital Oncology
- Vol. 13
Abstract
No abstract availableFunding Information
- Direction de l’hospitalisation et de l’offre de Soins
- Ministère des Solidarités et de la Santé (PHRC-K 25-174)
- Ministère des Solidarités et de la Santé (INCa-DGOS_20447)
This publication has 34 references indexed in Scilit:
- Proton pump inhibitors and cancer treatments: Emerging evidence against coadministrationCancer Treatment Reviews, 2024
- Causal Directed Acyclic GraphsJAMA, 2022
- Prevalence of Proton Pump Inhibitor Use Among Patients With CancerJAMA Network Open, 2021
- Effects of Histamine 2-receptor Antagonists and Proton Pump Inhibitors on the Pharmacokinetics of Gefitinib in Patients With Non–small-cell Lung CancerClinical Lung Cancer, 2017
- Does Cox analysis of a randomized survival study yield a causal treatment effect?Lifetime Data Analysis, 2015
- The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubtStatistics in Medicine, 2011
- The estimation of average hazard ratios by weighted Cox regressionStatistics in Medicine, 2009
- Imputing missing covariate values for the Cox modelStatistics in Medicine, 2009
- Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeuticsPharmacoepidemiology and Drug Safety, 2006
- Adjusted survival curves with inverse probability weightsComputer Methods and Programs in Biomedicine, 2004